Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Genetically elevated C-reactive protein and ischemic vascular disease.

Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG.

N Engl J Med. 2008 Oct 30;359(18):1897-908. doi: 10.1056/NEJMoa0707402.

2.

[C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].

Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG.

Ugeskr Laeger. 2009 May 18;171(21):1751-5. Danish.

PMID:
19492468
3.

C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease.

Zacho J, Tybjaerg-Hansen A, Nordestgaard BG.

Scand J Clin Lab Invest. 2009;69(4):442-6. doi: 10.1080/00365510903056015. Review.

PMID:
19533498
4.

Genetically elevated C-reactive protein and vascular disease.

Morita H, Nagai R.

N Engl J Med. 2009 Feb 26;360(9):934; author reply 934-5. No abstract available.

PMID:
19256031
5.

Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population.

Marott SC, Nordestgaard BG, Zacho J, Friberg J, Jensen GB, Tybjaerg-Hansen A, Benn M.

J Am Coll Cardiol. 2010 Aug 31;56(10):789-95. doi: 10.1016/j.jacc.2010.02.066.

6.

Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population.

Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG.

Stroke. 2015 Feb;46(2):329-35. doi: 10.1161/STROKEAHA.114.007657.

7.

Genetic variation in liver X receptor alpha and risk of ischemic vascular disease in the general population.

Stender S, Frikke-Schmidt R, Anestis A, Kardassis D, Sethi AA, Nordestgaard BG, Tybjærg-Hansen A.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2990-6. doi: 10.1161/ATVBAHA.111.223867. Epub 2011 Sep 8.

8.

Increased Baseline C-Reactive Protein Concentrations Are Associated with Increased Risk of Infections: Results from 2 Large Danish Population Cohorts.

Zacho J, Benfield T, Tybjærg-Hansen A, Nordestgaard BG.

Clin Chem. 2016 Feb;62(2):335-42. doi: 10.1373/clinchem.2015.249680. Epub 2015 Dec 31.

9.

Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.

Campbell DJ, Woodward M, Chalmers JP, Colman SA, Jenkins AJ, Kemp BE, Neal BC, Patel A, MacMahon SW.

Hypertension. 2005 Jan;45(1):69-74. Epub 2004 Nov 29.

10.

Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease.

Hornstrup LS, Tybjærg-Hansen A, Haase CL, Nordestgaard BG, Sillesen H, Grande P, Frikke-Schmidt R.

Circ Cardiovasc Genet. 2011 Oct;4(5):534-41. doi: 10.1161/CIRCGENETICS.110.958801. Epub 2011 Aug 10.

11.

Elevated C-reactive protein, depression, somatic diseases, and all-cause mortality: a mendelian randomization study.

Wium-Andersen MK, Orsted DD, Nordestgaard BG.

Biol Psychiatry. 2014 Aug 1;76(3):249-57. doi: 10.1016/j.biopsych.2013.10.009. Epub 2013 Oct 12.

PMID:
24246360
12.

Genetically elevated C-reactive protein and vascular disease.

Bubb MR.

N Engl J Med. 2009 Feb 26;360(9):933-4; author reply 934-5. No abstract available.

PMID:
19256030
13.

Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease.

Freiberg JJ, Tybjaerg-Hansen A, Sillesen H, Jensen GB, Nordestgaard BG.

Arterioscler Thromb Vasc Biol. 2008 May;28(5):990-6. doi: 10.1161/ATVBAHA.107.158873. Epub 2008 Feb 14.

14.

C-reactive protein and risk of venous thromboembolism in the general population.

Zacho J, Tybjaerg-Hansen A, Nordestgaard BG.

Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1672-8. doi: 10.1161/ATVBAHA.109.198473. Epub 2010 May 13.

15.

Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease.

Sethi AA, Nordestgaard BG, Grønholdt ML, Steffensen R, Jensen G, Tybjaerg-Hansen A.

Hypertension. 2003 Jun;41(6):1202-11. Epub 2003 May 12.

16.

Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent stroke.

Williams SR, Hsu FC, Keene KL, Chen WM, Nelson S, Southerland AM, Madden EB, Coull B, Gogarten SM, Furie KL, Dzhivhuho G, Rowles JL, Mehndiratta P, Malik R, Dupuis J, Lin H, Seshadri S, Rich SS, Sale MM, Worrall BB; METASTROKE, The Genomics and Randomized Trials Network (GARNET) Collaborative Research Group; METASTROKE The Genomics and Randomized Trials Network GARNET Collaborative Research Group.

Neurology. 2016 Jan 26;86(4):351-9. doi: 10.1212/WNL.0000000000002319. Epub 2015 Dec 30.

17.

Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke.

den Hertog HM, van den Herik EG, Dippel DW, Koudstaal PJ, de Maat MP.

Cerebrovasc Dis. 2010;29(4):372-5. doi: 10.1159/000281835. Epub 2010 Feb 9.

PMID:
20145391
18.

Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.

Johannsen TH, Kamstrup PR, Andersen RV, Jensen GB, Sillesen H, Tybjaerg-Hansen A, Nordestgaard BG.

J Clin Endocrinol Metab. 2009 Apr;94(4):1264-73. doi: 10.1210/jc.2008-1342. Epub 2008 Dec 16.

PMID:
19088157
19.

Cerebral small vessel disease and C-reactive protein: results of a cross-sectional study in community-based Japanese elderly.

Wada M, Nagasawa H, Kurita K, Koyama S, Arawaka S, Kawanami T, Tajima K, Daimon M, Kato T.

J Neurol Sci. 2008 Jan 15;264(1-2):43-9. Epub 2007 Aug 1.

PMID:
17673235
20.

Polymorphism in the C-reactive protein (CRP) gene affects CRP levels in plasma and one early marker of atherosclerosis in men: The Health 2000 Survey.

Kettunen T, Eklund C, Kähönen M, Jula A, Päivä H, Lyytikäinen LP, Hurme M, Lehtimäki T.

Scand J Clin Lab Invest. 2011 Sep;71(5):353-61. doi: 10.3109/00365513.2011.568123. Epub 2011 Mar 17.

PMID:
21413847

Supplemental Content

Support Center